PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1596089
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1596089
Hospital-Acquired Infection Control Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)
Market Overview
The global hospital-acquired infection (HAI) control market is projected to generate $30.9 billion in revenue in 2024 and is expected to reach $34.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 2.0% during the forecast period from 2024 to 2030. This growth is primarily driven by the increasing number of surgical procedures, growing awareness of environmental and personal hygiene, and the subsequent rise in the prevalence of chronic diseases. The necessity to control HAIs is underscored by the fact that they result in more fatalities annually than car accidents, breast cancer, or AIDS. Additionally, the COVID-19 pandemic has heightened consumer awareness regarding hygiene, further propelling the demand for effective HAI control measures.
Key Insights
The market is segmented by product type into consumables and instruments. Consumables, including disinfectants and sterilization supplies, constitute a significant portion of the market due to their recurrent use in healthcare settings. Instruments, such as sterilization and disinfection equipment, also hold a substantial share, driven by the need for advanced technologies to ensure effective infection control.
In terms of procedure type, the market is divided into disinfection and sterilization. Disinfection procedures are widely adopted for their efficacy in eliminating pathogens on surfaces and equipment. Sterilization procedures are essential for ensuring the complete eradication of microorganisms, particularly in surgical instruments and critical medical devices.
The end-user segment includes hospitals and clinics, infection control service providers, and ambulatory surgical care centers. Hospitals and clinics represent the largest end-user category, attributed to the high volume of patients and the critical need for stringent infection control measures in these settings. Infection control service providers and ambulatory surgical care centers also contribute to the market, emphasizing the importance of infection prevention across various healthcare facilities.
Geographically, North America holds the largest share of the HAI control market, driven by advanced healthcare infrastructure and stringent regulatory standards. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, attributed to increasing healthcare investments, rising awareness of infection control, and the growing prevalence of chronic diseases.
Technological advancements are significantly shaping the HAI control market. Innovations in sterilization and disinfection technologies, such as the development of automated systems and the integration of artificial intelligence for monitoring infection control practices, are enhancing the efficacy and efficiency of HAI prevention measures. These advancements are enabling healthcare facilities to implement more effective infection control protocols, thereby reducing the incidence of HAIs.
The market is characterized by fragmentation, with numerous players offering a diverse range of products and services. Key companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to expand their product portfolios and geographic presence. The increasing emphasis on patient safety, coupled with the growing demand for cost-effective and efficient infection control solutions, presents significant opportunities for innovation and growth within the HAI control market. As healthcare facilities continue to prioritize infection prevention, the adoption of advanced HAI control measures is expected to rise, driving the market's expansion in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by procedure type
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product Type (2019-2030)
- 6.3. Market Revenue, by Procedure Type (2019-2030)
- 6.4. Market Revenue, by End User (2019-2030)
- 6.5. Market Revenue, by Region (2019-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2019-2030)
- 7.3. Market Revenue, by Procedure Type (2019-2030)
- 7.4. Market Revenue, by End User (2019-2030)
- 7.5. Market Revenue, by Country (2019-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2019-2030)
- 8.3. Market Revenue, by Procedure Type (2019-2030)
- 8.4. Market Revenue, by End User (2019-2030)
- 8.5. Market Revenue, by Country (2019-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2019-2030)
- 9.3. Market Revenue, by Procedure Type (2019-2030)
- 9.4. Market Revenue, by End User (2019-2030)
- 9.5. Market Revenue, by Country (2019-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2019-2030)
- 10.3. Market Revenue, by Procedure Type (2019-2030)
- 10.4. Market Revenue, by End User (2019-2030)
- 10.5. Market Revenue, by Country (2019-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2019-2030)
- 11.3. Market Revenue, by Procedure Type (2019-2030)
- 11.4. Market Revenue, by End User (2019-2030)
- 11.5. Market Revenue, by Country (2019-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2019-2030)
- 12.3. Market Revenue, by Procedure Type (2019-2030)
- 12.4. Market Revenue, by End User (2019-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2019-2030)
- 13.3. Market Revenue, by Procedure Type (2019-2030)
- 13.4. Market Revenue, by End User (2019-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2019-2030)
- 14.3. Market Revenue, by Procedure Type (2019-2030)
- 14.4. Market Revenue, by End User (2019-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2019-2030)
- 15.3. Market Revenue, by Procedure Type (2019-2030)
- 15.4. Market Revenue, by End User (2019-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2019-2030)
- 16.3. Market Revenue, by Procedure Type (2019-2030)
- 16.4. Market Revenue, by End User (2019-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2019-2030)
- 17.3. Market Revenue, by Procedure Type (2019-2030)
- 17.4. Market Revenue, by End User (2019-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2019-2030)
- 18.3. Market Revenue, by Procedure Type (2019-2030)
- 18.4. Market Revenue, by End User (2019-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2019-2030)
- 19.3. Market Revenue, by Procedure Type (2019-2030)
- 19.4. Market Revenue, by End User (2019-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2019-2030)
- 20.3. Market Revenue, by Procedure Type (2019-2030)
- 20.4. Market Revenue, by End User (2019-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2019-2030)
- 21.3. Market Revenue, by Procedure Type (2019-2030)
- 21.4. Market Revenue, by End User (2019-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2019-2030)
- 22.3. Market Revenue, by Procedure Type (2019-2030)
- 22.4. Market Revenue, by End User (2019-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2019-2030)
- 23.3. Market Revenue, by Procedure Type (2019-2030)
- 23.4. Market Revenue, by End User (2019-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2019-2030)
- 24.3. Market Revenue, by Procedure Type (2019-2030)
- 24.4. Market Revenue, by End User (2019-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2019-2030)
- 25.3. Market Revenue, by Procedure Type (2019-2030)
- 25.4. Market Revenue, by End User (2019-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2019-2030)
- 26.3. Market Revenue, by Procedure Type (2019-2030)
- 26.4. Market Revenue, by End User (2019-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2019-2030)
- 27.3. Market Revenue, by Procedure Type (2019-2030)
- 27.4. Market Revenue, by End User (2019-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2019-2030)
- 28.3. Market Revenue, by Procedure Type (2019-2030)
- 28.4. Market Revenue, by End User (2019-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. STERIS plc
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Sotera Health Company
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Getinge AB
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Advanced Sterilization Products (ASP)
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Ecolab Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. 3M Company
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. MATACHANA GROUP
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Belimed AG
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Reckitt Benckiser Group plc
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Becton, Dickinson and Company
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. Johnson and Johnson (Ethicon)
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. Contec Inc.
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
